Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 18, Issue 20, pp. 5806-5815
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 20, 2012
- Revision received July 25, 2012
- Accepted August 13, 2012
- Published first August 21, 2012.
Article Versions
- Previous version (August 21, 2012 - 06:59).
- Previous version (September 28, 2012 - 07:15).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Zhigang C. Wang1,
- Nicolai Juul Birkbak1,6,
- Aedín C. Culhane2,
- Ronny Drapkin3,4,
- Aquila Fatima1,
- Ruiyang Tian1,
- Matthew Schwede2,
- Kathryn Alsop10,
- Kathryn E. Daniels3,
- Huiying Piao3,4,
- Joyce Liu3,
- Dariush Etemadmoghadam7,8,9,
- Alexander Miron1,
- Helga B. Salvesen12,13,
- Gillian Mitchell10,
- Anna DeFazio11,
- John Quackenbush2,
- Ross S. Berkowitz5,
- J. Dirk Iglehart1,
- David D.L. Bowtell7,8,9,
- for the Australian Ovarian Cancer Study Group, and
- Ursula A. Matulonis3
- Authors' Affiliations: Departments of 1Cancer Biology, 2Biostatistics and Computational Biology, and 3Medical Oncology, Dana-Farber Cancer Institute; 4Department of Pathology and 5Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts; 6Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark; 7Cancer Genomics Program, Departments of 8Biochemistry and 9Pathology, and 10Familial Cancer Centre, Peter MacCallum Cancer Centre and the University of Melbourne, Parkville, Melbourne, Victoria; 11Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia; 12Department of Obstetrics and Gynecology, Haukeland University Hospital; and 13Department of Clinical Medicine, University of Bergen, Bergen, Norway
- Corresponding Authors:
J. Dirk Iglehart, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215. Phone: 617-632-5178; Fax: 617-632-3709; E-mail: jiglehart{at}partners.org; and Ursula A. Matulonis, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215. Phone: 617-632-2334; Fax: 617-632-3479; E-mail: umatulonis{at}partners.org
October 2012
Volume 18, Issue 20
Volume 18, Issue 20
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
Jump to section
Advertisement